Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Erwin

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Journal of Applied Clinical Medical Physics|May 13, 2017
AAPM medical physics practice guideline 6.a.: Performance characteristics of radiation dose index monitoring systemsDustin A Gress, Renee L Dickinson, William D Erwin, et al.
Clinical Nuclear Medicine|February 2, 2016
Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra TherapyElba C Etchebehere, John C Araujo, Denái R Milton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodiesD A DeNardo, G L DeNardo, A Yuan, et al.
Cancer|March 6, 2002
Radiation dosimetry results for Zevalin radioimmunotherapy of rituximab-refractory non-Hodgkin lymphomaGregory A Wiseman, Bryan Leigh, William D Erwin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Planar imaging versus gated blood-pool SPECT for the assessment of ventricular performance: a multicenter studyM W Groch, E G DePuey, A C Belzberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasiaIsis W Gayed, E Edmund Kim, William F Broussard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 28, 2009
Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancerNaomi R Schechter, William D Erwin, David J Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapyHazel B Breitz, Richard E Wendt, Michael S Stabin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neckNaomi R Schechter, Richard E Wendt, David J Yang, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2003
Radiation dosimetry results from a Phase II trial of ibritumomab tiuxetan (Zevalin) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopeniaGregory A Wiseman, Bryan R Leigh, William D Erwin, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Journal of Applied Clinical Medical Physics|May 13, 2017
AAPM medical physics practice guideline 6.a.: Performance characteristics of radiation dose index monitoring systemsDustin A Gress, Renee L Dickinson, William D Erwin, et al.
Clinical Nuclear Medicine|February 2, 2016
Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra TherapyElba C Etchebehere, John C Araujo, Denái R Milton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodiesD A DeNardo, G L DeNardo, A Yuan, et al.
Cancer|March 6, 2002
Radiation dosimetry results for Zevalin radioimmunotherapy of rituximab-refractory non-Hodgkin lymphomaGregory A Wiseman, Bryan Leigh, William D Erwin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Planar imaging versus gated blood-pool SPECT for the assessment of ventricular performance: a multicenter studyM W Groch, E G DePuey, A C Belzberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2005
The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasiaIsis W Gayed, E Edmund Kim, William F Broussard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 28, 2009
Radiation dosimetry and biodistribution of (99m)Tc-ethylene dicysteine-deoxyglucose in patients with non-small-cell lung cancerNaomi R Schechter, William D Erwin, David J Yang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapyHazel B Breitz, Richard E Wendt, Michael S Stabin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 9, 2004
Radiation dosimetry of 99mTc-labeled C225 in patients with squamous cell carcinoma of the head and neckNaomi R Schechter, Richard E Wendt, David J Yang, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2003
Radiation dosimetry results from a Phase II trial of ibritumomab tiuxetan (Zevalin) radioimmunotherapy for patients with non-Hodgkin's lymphoma and mild thrombocytopeniaGregory A Wiseman, Bryan R Leigh, William D Erwin, et al.
Pageof 9